Interpretation of the 13C-urea breath test in the choice of second- and third-line eradication of Helicobacter pylori infection

被引:7
|
作者
Buzas, Gyoergy M. [1 ]
Szeles, Ilona
机构
[1] Ferencvaros Hlth Ctr, H-1095 Budapest, Hungary
关键词
eradication; Helicobacter pylori; urea breath test;
D O I
10.1007/s00535-007-2135-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background The urea breath test (UBT) is one of the most accurate methods of assessing Helicobacter pylori status. The predictive value of the test is, however, uncertain. This study was a serial, prospective analysis of the change over time of UBT values after first-, second- and third-line treatments of patients with failed eradication therapy. Methods. One hundred thirty-four duodenal ulcer patients with persisting H. pylori infection after first-line triple therapy were enrolled in a cross-over manner to receive either pantoprazole (40 mg twice daily), amoxicillin (1000 mg twice daily), and clarithromycin (500 mg) or ranitidine bismuth citrate (400 mg twice daily), metronidazole (250 mg twice daily), and clarithromycin (500 mg twice daily) for 7 days. Forty-one patients with failed second-line treatment were randomized to receive third-line quadruple therapies with pantoprazole + amoxicillin and tetracycline (500 mg four times daily) and either nitrofurantoin (100 mg three times daily) or bismuth subsalicylate (120 mg four times daily). Breath tests were performed 6 weeks after therapy. The delta(CO2)-C-13 values (%omicron) after primary, secondary, and tertiary treatment were analyzed, and the correlation between pretreatment values and the rate of H. pylori eradication was assessed. Results. In patients with successful second-line treatment, UBT values decreased from 12.4%omicron [confidence interval (CI), 9.7-15.7)] to 2.8%omicron (CI, 0.9-2.5) (P = 0.001), and in those with persistent infection, they increased from 13.2%omicron (CI, 7.3-19.1) to 19.2%omicron (CI, 13.4-25.0) (P = 0.03). After a failed quadruple regimen, UBT values increased from 19.3%omicron (CI, 16.2-22.4) to 25.8%omicron (CI, 19.8-312.8) (P = 0.03). The correlation between the pretreatment UBT values and the rate of eradication was negative for both second- and third-line therapies. Conclusions. Serial assessment showed that UBT values after successive treatments showed a marked tendency
引用
收藏
页码:108 / 114
页数:7
相关论文
共 50 条
  • [1] Interpretation of the 13C-urea breath test in the choice of second- and third-line eradication of Helicobacter pylori infection
    György M. Buzás
    Ilona Széles
    [J]. Journal of Gastroenterology, 2008, 43 : 108 - 114
  • [2] 13C-Urea Breath Test Values and Helicobacter pylori Eradication
    Angelo Zullo
    Federico Perna
    Chiara Ricci
    Cesare Hassan
    Andrea Tampieri
    Vincenzo De Francesco
    Sergio Morini
    Dino Vaira
    [J]. Digestive Diseases and Sciences, 2008, 53 : 370 - 374
  • [3] 13C-urea breath test values and Helicobacter pylori eradication
    Zullo, Angelo
    Perna, Federico
    Ricci, Chiara
    Hassan, Cesare
    Tampieri, Andrea
    De Francesco, Vincenzo
    Morini, Sergio
    Vaira, Dino
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (02) : 370 - 374
  • [4] Definition of eradication of Helicobacter pylori infection can be revised by 13C-urea breath test
    Yang, JC
    Kuo, YN
    Lee, SC
    Ting, G
    Wang, JT
    Wang, TH
    [J]. GUT, 2001, 49 : A100 - A100
  • [5] 13C-Urea breath test for the diagnosis of Helicobacter pylori infection
    Di Rienzo, T. A.
    D'Angelo, G.
    Ojetti, V.
    Campanale, M. C.
    Tortora, A.
    Cesario, V.
    Zuccala, G.
    Franceschi, F.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 : 51 - 58
  • [6] 13C-urea breath test in the management of Helicobacter pylori infection
    Gisbert, JP
    Pajares, JM
    [J]. DIGESTIVE AND LIVER DISEASE, 2005, 37 (12) : 899 - 906
  • [7] Dual therapy for third-line Helicobacter pylori eradication and urea breath test prediction
    Nishizawa, Toshihiro
    Suzuki, Hidekazu
    Maekawa, Takama
    Harada, Naohiko
    Toyokawa, Tatsuya
    Kuwai, Toshio
    Ohara, Masanori
    Suzuki, Takahiro
    Kawanishi, Masahiro
    Noguchi, Kenji
    Yoshio, Toshiyuki
    Katsushima, Shinji
    Tsuruta, Hideo
    Masuda, Eiji
    Tanaka, Munehiro
    Katayama, Shunsuke
    Kawamura, Norio
    Nishizawa, Yuko
    Hibi, Toshifumi
    Takahashi, Masahiko
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (21) : 2735 - 2738
  • [8] Dual therapy for third-line Helicobacter pylori eradication and urea breath test prediction
    Toshihiro Nishizawa
    Hidekazu Suzuki
    Takama Maekawa
    Naohiko Harada
    Tatsuya Toyokawa
    Toshio Kuwai
    Masanori Ohara
    Takahiro Suzuki
    Masahiro Kawanishi
    Kenji Noguchi
    Toshiyuki Yoshio
    Shinji Katsushima
    Hideo Tsuruta
    Eiji Masuda
    Munehiro Tanaka
    Shunsuke Katayama
    Norio Kawamura
    Yuko Nishizawa
    Toshifumi Hibi
    Masahiko Takahashi
    [J]. World Journal of Gastroenterology, 2012, (21) : 2735 - 2738
  • [9] Evaluation of endoscopic 13C-urea breath test for assessment of Helicobacter pylori eradication
    Suto, H
    Azuma, T
    Ito, S
    Ito, Y
    Miyaji, H
    Yamazaki, Y
    Kohli, Y
    Kuriyama, M
    [J]. JOURNAL OF GASTROENTEROLOGY, 1999, 34 : 67 - 71
  • [10] 13C-urea breath test to validate eradication of Helicobacter pylori in an Israeli population
    Gal, E
    Abuksis, G
    Fraser, G
    Koren, R
    Shmueli, C
    Yahav, Y
    Niv, Y
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (02): : 98 - 100